Subversive Growth 100 Redacted ETF (NY:XXQQ)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 24.80 |
| Bid (Size) | 9.980 (100) |
| Ask (Size) | 39.43 (100) |
| Prev. Close | 24.80 |
| Today's Range | 24.80 - 24.80 |
| 52wk Range | 24.80 - 24.84 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Performance
52-Week Range
0.1% below 52-week high
24.80
24.8052W Low
24.8452W High
1 Week
0.1% below 1-week high
24.801W Low
24.841W High
Subversive Growth 100 Redacted ETF (XXQQ) traded between $24.80 and $24.84 over the past 52 weeks and last traded at $24.80, 0.1% below its 52-week high. Over the past week it ranged between $24.80 and $24.84.
Past 12 Months
1W
1M
3M
6M
YTD
1Y
12 Months vs Market
XXQQ
N/A
DIA
+12.0%
SPY
+17.4%
QQQ
+24.8%
IWM
+14.1%
Over the past 12 months XXQQ returned N/A versus DIA (Dow) +12.0%, SPY (S&P 500) +17.4%, QQQ (Nasdaq 100) +24.8% and IWM (Russell 2000) +14.1%.
Volume & Liquidity
1W
13.0K
1M
13.0K
3M
13.0K
6M
13.0K
YTD
13.0K
1Y
13.0K
XXQQ's 3-month average daily volume is 13.0K.
Frequently Asked Questions
Is Subversive Growth 100 Redacted ETF publicly traded?
Yes, Subversive Growth 100 Redacted ETF is publicly traded.
What exchange does Subversive Growth 100 Redacted ETF trade on?
Subversive Growth 100 Redacted ETF trades on the New York Stock Exchange
What is the ticker symbol for Subversive Growth 100 Redacted ETF?
The ticker symbol for Subversive Growth 100 Redacted ETF is XXQQ on the New York Stock Exchange
What is the current price of Subversive Growth 100 Redacted ETF?
The current price of Subversive Growth 100 Redacted ETF is 24.80
When was Subversive Growth 100 Redacted ETF last traded?
The last trade of Subversive Growth 100 Redacted ETF was at 10/09/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.